Sartorius CellGenix GmbH
Mazhar Gull (PhD) is an experienced professional in the field of life sciences, currently serving as Market Research Manager at Sartorius CellGenix GmbH since December 2020. In this role, Mazhar conducts comprehensive analyses of the global cell and gene therapy market, oversees product management from conception to market positioning, and facilitates communication across multiple departments concerning product-related topics. Prior to this position, Mazhar worked as a Thought Leadership Analyst at IQVIA Germany, focusing on pharmaceutical industry trends, and held research scientist roles at prestigious institutions, including the Biomedical Center Munich and Ludwig-Maximilians-Universität München, where extensive research was conducted in pharmacological and toxicological profiling. Mazhar holds a PhD in Natural Sciences and has a robust academic background with multiple degrees in molecular biology and biological sciences.
This person is not in any teams
Sartorius CellGenix GmbH
Sartorius CellGenix is a leading global supplier of high quality raw and ancillary materials for the expanding market of cell and gene therapy and regenerative medicine. We develop, manufacture and market human cytokines, growth factors, and other recombinant cell culture components in preclinical and GMP quality as well as prorietary serum-free media for further manufacturing of ATMPs. Our products are used by academia and industry partners in clinical trials and commercial manufacturing throughout the world. As an ATMP developer and manufacturer we gained in-depth cell culture knowledge and superior regulatory expertise. With this unique background we understand the high requirements our customers face during product development and the regulatory approval process. Sartorius CellGenix is headquartered in Freiburg, Germany.